Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | MYC | P01106 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | TPMT | P51580 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30100430 | 1.00 | CSNK2A1 (0.59) | CSNK2A1ALDH1A1KDM4EHPGDACHE | |
| SCHEMBL28837028 | 0.88 | CSNK2A1 (0.59) | CSNK2A1ALDH1A1KDM4EHPGDMYC | |
| SCHEMBL365917 | 0.86 | ALDH1A1 (0.65) | CSNK2A1ALDH1A1KDM4EHPGDACHE | |
| SCHEMBL9726812 | 0.85 | ACHE (0.58) | ALDH1A1HPGDACHEMAPTHSD17B10 | |
| SCHEMBL27376288 | 0.84 | CSNK2A1 (0.55) | CSNK2A1ALDH1A1KDM4EHPGDMYC | |
| SCHEMBL11003356 | 0.84 | CSNK2A1 (0.55) | CSNK2A1ALDH1A1KDM4EHPGDMYC | |
| SCHEMBL29678114 | 0.84 | CSNK2A1 (0.55) | CSNK2A1ALDH1A1KDM4EHPGDMYC | |
| SCHEMBL20377181 | 0.84 | CSNK2A1 (0.55) | CSNK2A1ALDH1A1KDM4EHPGDMYC | |
| SCHEMBL1210111 | 0.83 | SRC (0.58) | ALDH1A1KDM4EACHECA9MAPT | |
| SCHEMBL30482833 | 0.83 | SRC (0.58) | ALDH1A1KDM4EACHECA9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3112352-A1 | OPIOID RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2017-01-04 | — | — | EP | claimed |
| EP-1725537-B1 | NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-07-13 | — | — | EP | claimed |
| US-5942365-A | CHARGE ADJUVANT OF ALUMINUM SALT OF AN ACID; SMEARING, LOSS OF RESOLUTION AND LOSS OF DENSITY ELIMINATED OR MINIMIZED | XEROX CORPORATION (US) | 1999-08-24 | — | — | US | claimed |
| US-12630541-B2 | Compounds useful as inhibitors of ALCAT 1 | PERENNA PHARMACEUTICALS, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| EP-3782994-B1 | COMPOUNDS USEFUL AS KINASE INHIBITORS | LOXO ONCOLOGY INC (US) | 2025-07-16 | — | — | EP | disclosed |
| CN-120136858-A | Compounds useful as ALCAT1 inhibitors | 中美博瑞纳制药有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20250090500-A1 | COMPOUNDS USEFUL AS KINASE INHIBITORS | LOXO ONCOLOGY, INC. | 2025-03-20 | — | — | US | disclosed |
| CN-114716381-B | Compounds useful as kinase inhibitors | 洛克索肿瘤学股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-114605327-B | Compounds useful as kinase inhibitors | 洛克索肿瘤学股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-114573510-B | Compounds useful as kinase inhibitors | 洛克索肿瘤学股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-110709394-B | Compounds useful as ALCAT1 inhibitors | 中美博瑞纳制药有限公司 | 2025-02-21 | — | — | CN | disclosed |
| EP-0204472-A2 | Cleaning compositions | THE PROCTER & GAMBLE COMPANY (US) | 1986-12-10 | — | — | EP | disclosed |
| EP-0187487-A1 | Benzothiophenes and benzofurans having antiallergic activity | WARNER-LAMBERT COMPANY (US) | 1986-07-16 | — | — | EP | disclosed |
| US-4576728-A | AMINE OXIDE, BENZOIC ACID DERIVATIVE HIGH VISCOSITY | THE PROCTER & GAMBLE COMPANY (US) | 1986-03-18 | — | — | US | disclosed |
| US-4525304-A | Process for preparing oxazolinoazetidinones | ELI LILLY AND COMPANY (US) | 1985-06-25 | — | — | US | disclosed |
| EP-0144166-A2 | Cleaning compositions | THE PROCTER & GAMBLE COMPANY (US) | 1985-06-12 | — | — | EP | disclosed |
| US-4470977-A | 3-CHLORO-N-(1-ETHYL-2-PYRROLIDINYLMETHYL2-METHOXYBENZAMIDE | ADRIA LABORATORIES, INC. (US) | 1984-09-11 | — | — | US | disclosed |
| EP-0105599-A1 | Antiemetic and antipsychotic agents | ADRIA LABORATORIES, INC. (US) | 1984-04-18 | — | — | EP | disclosed |
| US-4278680-A | Hypoglycaemically and hypolipidaemically active derivatives of phenylacetic acid | BOEHRINGER MANNHEIM GMBH (DE) | 1981-07-14 | — | — | US | disclosed |
| US-4207341-A | Hypoglycaemically and hypolipidaemically active derivatives of phenylacetic acid | BOEHRINGER-MANNHEIM GMBH (DE) | 1980-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630541-B2 | Compounds useful as inhibitors of ALCAT 1 | LCLAT1, LPCAT1, ACAT2 | CSNK2A1 1414/4885ALDH1A1 511/4885KDM4E 3151/4885 |
| US-20250090500-A1 | COMPOUNDS USEFUL AS KINASE INHIBITORS | BTK, ABL1, LCK | CSNK2A1 446/4885ALDH1A1 4454/4885KDM4E 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.